|
End-of-day quote
NSE India S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 847.30 INR | -2.53% |
|
+1.32% | +12.75% |
| 26/09 | Supriya Lifescience Limited Approves Final Dividend for the Financial Year Ended March 31, 2026 | CI |
| 14/08 | Supriya Lifescience Limited, Q1 2027 Earnings Call, Aug 14, 2026 |
| Market Cap | 68.19B 718M 643M 592M 536M 1B 1.02B 7.06B 2.83B 35.87B 2.7B 2.64B 113B | P/E 2027 * |
28.7x | P/E 2028 * | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 68.19B 718M 643M 592M 536M 1B 1.02B 7.06B 2.83B 35.87B 2.7B 2.64B 113B | EV / Sales 2027 * |
6.86x | EV / Sales 2028 * | 5.49x |
| Free-Float |
28.72% | Yield 2027 * |
-
| Yield 2028 * | - |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| SUPRIYA | End-of-day quote | |
Bombay S.E.
| SUPRIYA | Delayed |
Last Transcript: Supriya Lifescience Limited
| 1 day | -2.53% | ||
| 1 week | +1.32% | ||
| Current month | -10.83% | ||
| 1 month | -13.98% | ||
| 3 months | -1.43% | ||
| 6 months | +21.35% | ||
| Current year | +12.75% |
| 1 week | 807.15 |  | 880.45 |
| 1 month | 801 | | 948.25 |
| Current year | 545.5 | | 1,085 |
| 1 year | 545.5 | | 1,085 |
| 3 years | 239.8 | | 1,085 |
| 5 years | 170.15 | | 1,085 |
| 10 years | 170.15 | | 1,085 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 35 | 01/08/2024 | |
| Chief Executive Officer | 36 | 01/08/2024 | |
| Director of Finance/CFO | - | 23/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 26/03/2008 | |
| Director/Board Member | 41 | 01/06/2019 | |
| Director/Board Member | 36 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.53% | +1.32% | +13.37% | +238.11% | 735M | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,224B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 662B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 514B | |
| +0.42% | +2.88% | +54.92% | +69.67% | 388B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 361B | |
| +1.12% | +3.80% | +35.82% | +59.72% | 302B | |
| +6.96% | +7.55% | +11.15% | +37.89% | 271B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 249B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 205B | |
| Average | +1.42% | +2.50% | +43.38% | +99.18% | 417.76B | |
| Weighted average by Cap. | +1.54% | +3.04% | +51.01% | +98.68% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 9.94B 105M 93.71M 86.2M 78.1M 146M 149M 1.03B 413M 5.23B 393M 384M 16.48B | 12.42B 131M 117M 108M 97.62M 182M 186M 1.28B 516M 6.53B 491M 480M 20.6B |
| Net income | 2.37B 24.98M 22.37M 20.58M 18.65M 34.86M 35.51M 245M 98.52M 1.25B 93.75M 91.76M 3.93B | 3.12B 32.88M 29.45M 27.09M 24.54M 45.88M 46.74M 323M 130M 1.64B 123M 121M 5.18B |
| Net Debt | - | - |
Employees
607
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | INR 847.30 | -2.53% | 92,052 |
| 29/10/26 | INR 869.30 | +0.82% | 87,175 |
| 28/10/26 | INR 862.25 | +1.33% | 199,541 |
| 27/10/26 | INR 850.90 | +2.14% | 91,955 |
| 26/10/26 | INR 833.05 | +1.77% | 90,442 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUPRIYA Stock
Select your edition
All financial news and data tailored to specific country editions
